Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,787,593
-
Share change
-
-745,384
-
Total reported value
-
$211,448,000
-
Price per share
-
$8.20
-
Number of holders
-
73
-
Value change
-
-$16,854,007
-
Number of buys
-
33
-
Number of sells
-
34
Institutional Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q4 2017
As of 31 Dec 2017 AVADEL PHARMACEUTICALS - COM (AVDL) had 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,787,593 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BRANDES INVESTMENT PARTNERS, LP, Broadfin Capital, LLC, PERCEPTIVE ADVISORS LLC, ARMISTICE CAPITAL, LLC, ACADIAN ASSET MANAGEMENT LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, and BROWN CAPITAL MANAGEMENT LLC.
This table shows 74 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.